Thermo Fisher to Expand its Clinical Trials Capabilities and Collaborates with Frontier to Develop Therapy for HIV

 Thermo Fisher to Expand its Clinical Trials Capabilities and Collaborates with Frontier to Develop Therapy for HIV

Thermo Fisher to Expand its Clinical Trials Capabilities and Collaborates with Frontier to Develop Therapy for HIV

Shots:

  • Thermo Fisher expands its clinical trials supply and distribution services network in China with the investment of $4.4M in its Suzhou facility to support the growth of clinical studies and to provide biotech companies with the resources to develop and commercialize new therapies in China
  • Additionally, Thermo Fisher collaborates with Frontier to expedite the commercialization of 3BNC117 and will be the exclusive manufacturing partner of 3BNC117 to support pivotal study, PPQ & global commercial supply by manufacturing it in its St. Louis facility
  • The new clinical trial facility adds 10°C-20°C beta-lactam storage, cold chain capacity, and increases current storage capacity for temperatures at 15°C to 25°C, 2°C to 8°C and -20°C making it Thermo Fisher’s largest clinical trial facility in Suzhou

Click here to­ read full press release/ article | Ref: Thermo Fisher | Image: BioTecNika

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post